{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:04:31Z","timestamp":1792112671042,"version":"4.4.0"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1097\/ftd.0b013e3182557d10","type":"journal-article","created":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T06:39:22Z","timestamp":1335854362000},"page":"245-248","source":"Crossref","is-referenced-by-count":9,"title":["Oral Aripiprazole-Induced Severe Hypoglycemia"],"prefix":"10.1097","volume":"34","author":[{"given":"Somnath","family":"Mondal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indranil","family":"Saha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saibal","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhrajit","family":"Ganguly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhinaba","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akhila","family":"Kumar Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R3-3-20210129","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1055\/s-2007-978960","article-title":". Electrocardiographic changes during insulin-induced hypoglycemia in healthy subjects.","volume":"30","author":"Meinhold","year":"1998","journal-title":"Horm Metab Res"},{"key":"R4-3-20210129","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/BF00343788","article-title":"Features of brain atrophy in Parkinsons disease. A CT scan study.","volume":"27","author":"Steiner","year":"1985","journal-title":"Neuroradiology"},{"key":"R5-3-20210129","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s00702-009-0231-z","article-title":". Aripiprazole in L-dopa-induced dyskinesias: a one-year open-label pilot study.","volume":"116","author":"Meco","year":"2009","journal-title":"J Neural Transm"},{"key":"R6-3-20210129","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S0009-9236(01)51508-8","article-title":". Losartan attenuates symptomatic and hormonal responses to hypoglycemia in humans.","volume":"70","author":"Deininger","year":"2001","journal-title":"Clin Pharmacol Ther"},{"key":"R8-3-20210129","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s12272-010-0414-z","article-title":". Enhanced effect of losartan and rosuvastatin on neointima hyperplasia.","volume":"33","author":"Yi","year":"2010","journal-title":"Arch Pharm Res"},{"key":"R9-3-20210129","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":". A method for estimating the probability of adverse drug reactions.","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"R10-3-20210129","doi-asserted-by":"crossref","first-page":"215","DOI":"10.4088\/JCP.v60n0402","article-title":". The distribution of body mass index among individuals with and without schizophrenia.","volume":"60","author":"Allison","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"R11-3-20210129","first-page":"1591","article-title":"Risk of diabetes mellitus with atypical antipsychotic drugs in French.","volume":"62","author":"Scheen","year":"2004","journal-title":"Med Hyg"},{"key":"R12-3-20210129","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1016\/j.clinthera.2004.12.003","article-title":"Metabolic risk during antipsychotic treatment.","volume":"26","author":"Newcomer","year":"2004","journal-title":"Clin Ther"},{"key":"R13-3-20210129","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.4088\/JCP.v66n1117","article-title":"Undiagnosed hyperglycemia in patients treated with atypical antipsychotics.","volume":"66","author":"Sermyak","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"R14-3-20210129","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.2337\/diacare.26.11.3202","article-title":"Patients on atypical antipsychotic drugs: another high-risk group for type 2 diabetes.","volume":"26","author":"Lean","year":"2003","journal-title":"Diabetes Care"},{"key":"R15-3-20210129","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.diabet.2007.01.003","article-title":"Abnormal glucose metabolism in patients treated with antipsychotics.","volume":"33","author":"Scheen","year":"2007","journal-title":"Diabetes Metab"},{"key":"R16-3-20210129","first-page":"234","article-title":"Drug-induced glucose alterations part 2: drug-induced hyperglycemia. Diabetes spectrum.","volume":"24","author":"Rehman","year":"2011","journal-title":"Pharm Ther"},{"key":"R17-3-20210129","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1093\/schbul\/sbl037","article-title":". A case series: evaluation of the metabolic safety of aripiprazole.","volume":"33","author":"De Hert","year":"2007","journal-title":"Schizophr Bull"},{"key":"R18-3-20210129","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1111\/j.1464-5491.2005.01628.x","article-title":"Diabetic ketoacidosis associated with aripiprazole.","volume":"22","author":"Church","year":"2005","journal-title":"Diabet Med"},{"key":"R19-3-20210129","first-page":"303","article-title":". Elevated lipase and diabetic ketoacidosis associated with aripiprazole.","volume":"7","author":"Reddymasu","year":"2006","journal-title":"JOP"},{"key":"R20-3-20210129","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1136\/bmj.a1792","article-title":". Hypoglycaemia induced by second generation antipsychotic agents in schizophrenic non-diabetic patients.","volume":"338","author":"Suzuki","year":"2009","journal-title":"BMJ"},{"key":"R21-3-20210129","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/1752-1947-2-155","article-title":"Diabetic control and atypical antipsychotics: a case report.","volume":"2","author":"Gaston","year":"2008","journal-title":"J Med Case Rep"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0b013e3182557d10","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:39:40Z","timestamp":1620952780000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007691-201206000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0b013e3182557d10","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}